| CARD ID | 893 | |
| Type of strain | Transgenic. | |
| Strain name | C57BL/6-Tg(CAG-hG8NC(null))N673-2Glp | |
| Internal Code | h Gal8NC(null) | |
| Submitter | - - | |
| Submitter affiliation or code | - | |
| Stock Type | ||
| Material Transfer Conditions |
Consent to us
|
|
| Production method | in-house breeding | |
| Origin (In-house) | Organization | Galpharma Co.Ltd. |
| Organization code | Gal | |
| Developer | Mitsuomi Hirashima | |
| Origin (From other organizations) | Organization | |
| Organization code | ||
| Developer | ||
| Year introduced | ||
| Introduced Generation | ||
| Remarks | ||
| Gene symbol | hG8NC(null) |
| Gene name | human Galectin 8NC(null) |
| Allele symbol | |
| Allele name | |
| MGI | |
| Chromosome | Unknown , |
| Gene classification | Gene to express(transgenic) |
| Method | MicroInjection |
| OMIM |
| h Gal-8.Forward | ggATCTgCAgAATggCAgCAgCAgCAT |
| h Gal-8.Reverse | gTCTCCATTAATTTCCAgCgTgTC |
| Author | Nishi N, Itoh A, Fujiyama A, Yoshida N, Araya S, Hirashima M, Shoji H, Nakamura T. |
| Title | Development of highly stable galectins: truncation of the linker peptide confers protease-resistance on tandem-repeat type galectins. |
| Journal | FEBS Lett. |
| Volume | 10 |
| Page | 2058-64 |
| Year | 2005 |
| PMID |
| Author | Nishi N, Shoji H, Seki M, Itoh A, Miyanaka H, Yuube K, Hirashima M, Nakamura T. |
| Title | Galectin-8 modulates neutrophil function via interaction with integrin alphaM. |
| Journal | Glycobiology. |
| Volume | 11 |
| Page | 755-63 |
| Year | 2003 |
| PMID |
| Disease name, Applicable field | Development, Immunology, cancer |